SCHEMBL7689367

SCHEMBL7689367

NC(=O)c1ccccc1Oc1ccc(S(N)(=O)=O)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTNNB1 P35222 1/20 0.68
SOS1 Q07889 2/20 0.57
ALDH1A1 P00352 1/20 0.55
HTT P42858 1/20 0.55
CA2 P00918 7/20 0.51
CA1 P00915 5/20 0.51
CA9 Q16790 5/20 0.51
CA12 O43570 4/20 0.51
CA4 P22748 2/20 0.48
SMN1; SMN2 Q16637 1/20 0.46
PARP10 Q53GL7 1/20 0.45
IRAK4 Q9NWZ3 1/20 0.45
CA14 Q9ULX7 2/20 0.44
CA7 P43166 2/20 0.44
IKBKB O14920 1/20 0.44
CHUK O15111 1/20 0.44
CA5A P35218 1/20 0.43
CA5B Q9Y2D0 1/20 0.43
MEN1 O00255 1/20 0.43
NR1I2 O75469 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2662702 0.86 CTNNB1 (0.66) CTNNB1HTTSMN1; SMN2PARP10IRAK4
SCHEMBL7688158 0.84 CTNNB1 (0.62) CTNNB1ALDH1A1CA2CA1CA9
SCHEMBL27680126 0.81 CTNNB1 (1.00) CTNNB1ALDH1A1HTTSMN1; SMN2PARP10
SCHEMBL5724 0.81 CTNNB1 (1.00) CTNNB1ALDH1A1HTTSMN1; SMN2PARP10
SCHEMBL28876495 0.81 CTNNB1 (1.00) CTNNB1ALDH1A1HTTSMN1; SMN2PARP10
SCHEMBL1892492 0.80 CTNNB1 (0.77) CTNNB1ALDH1A1SMN1; SMN2PARP10IRAK4
SCHEMBL27800575 0.80 CTNNB1 (0.77) CTNNB1ALDH1A1SMN1; SMN2PARP10IRAK4
Hydrochloric Acid SCHEMBL50731 0.80 CTNNB1 (0.96) CTNNB1ALDH1A1HTTSMN1; SMN2PARP10
SCHEMBL28081666 0.80 CTNNB1 (0.96) CTNNB1ALDH1A1HTTSMN1; SMN2PARP10
SCHEMBL6368241 0.79 CTNNB1 (0.74) CTNNB1ALDH1A1HTTSMN1; SMN2PARP10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002016356-A2 QUINUCLIDINE-SUBSTITUTED ARYL MOIETIES FOR TREATMENT OF DISEASE (NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS) PHARMACIA & UPJOHN COMPANY (US) 2002-02-28 WO claimed